Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder [NA]
A clinical trial evaluating imaging of serotonin 5-HT1A receptors in patients with major depressive disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study [NA]
The trial comparing supplemental Transcranial Magnetic Stimulation (TMS) to standard medication monotherapy for major depressive disorder ha…
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment [Phase 4]
Phase 4 trial evaluating risperidone augmentation in partial responders to SRIs for treatment-resistant depression was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-24Clinical Trial Update: The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems? [NA]
A clinical trial investigating memantine as an adjunct to electroconvulsive therapy for major depressive disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Intranasal Ketamine for Late-Life Depression and Suicidal Ideation [Phase 4]
A Phase 4 clinical trial evaluating intranasal esketamine for late-life depression and suicidal ideation has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy [NA]
This clinical trial update reports the withdrawal of a Kaiser Permanente study evaluating ultrabrief right unilateral and brief-pulse electr…
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Computer-Based Intervention in HIV-Positive Young Adults [NA]
The clinical trial NCT02544126 evaluating a computer-based intervention for HIV-positive young adults with depression has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-21Clinical Trial Update: Neuroimaging Predictors of Antidepressant Treatment Outcome [Phase 2]
A Phase 2 clinical trial from the University of Michigan investigating whether neuroimaging can predict antidepressant treatment outcomes fo…
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: Mood and Behavior Changes Among Overweight Adolescent Females
A University of Kentucky trial evaluating mood and behavior changes in overweight adolescent females has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives [Phase 4]
A Phase 4 trial evaluating vilazodone's effect on glutamate in the anterior cingulate cortex for patients with anxious major depressive diso…
-
CLINICAL_TRIALS withdrawal · 2016-10-13Clinical Trial Update: A Prospective Study of Body Image, Social Avoidance and Distress and Psychological Functioning in Burn Patients
The trial evaluating body image, social avoidance, distress, and psychological functioning in burn patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-07Clinical Trial Update: Primary Care iSBIRT to Reduce Serious Teen Health Risks [Phase 1, Phase 2]
Phase 1/2 trial of iSBIRT to reduce teen risk behaviors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-30Clinical Trial Update: Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers [Phase 4]
Phase 4 trial of vortioxetine for major depressive disorder, cognition, and systemic inflammatory biomarkers in breast cancer patients was w…
-
CLINICAL_TRIALS withdrawal · 2016-09-02Clinical Trial Update: Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI) [Phase 3]
A Phase 3 clinical trial evaluating vortioxetine for major depressive disorder with co-morbid conditions following traumatic brain injury ha…
-
CLINICAL_TRIALS withdrawal · 2016-08-25Clinical Trial Update: Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease [EARLY_Phase 1]
The early-phase trial of vortioxetine in patients with major depressive disorder and coronary artery disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-15Clinical Trial Update: Creatine Augmentation in Veterans With SSRI-Resistant Major Depression [Phase 4]
A Phase 4 trial evaluating creatine augmentation in veterans with SSRI-resistant major depression has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-07Clinical Trial Update: Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability [Phase 3]
A Phase 3 clinical trial of brexpiprazole for adults with major depressive disorder and irritability has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-17Clinical Trial Update: Duloxetine for the Treatment of Postpartum Depression [NA]
A Yale-sponsored clinical trial evaluating duloxetine for postpartum depression has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-01-05Clinical Trial Update: e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression [Phase 2]
A Phase 2 clinical trial evaluating personalized e-PAT neuromodulation with repetitive transcranial magnetic stimulation for treatment-resis…
-
CLINICAL_TRIALS withdrawal · 2015-12-21Clinical Trial Update: Exercise Training in Depressed Traumatic Brain Injury Survivors [NA]
A clinical trial examining exercise training for individuals with depression following traumatic brain injury was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-15Clinical Trial Update: Mobile Apps for the Treatment of Depression [NA]
The clinical trial evaluating mobile apps for treating major depressive disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder [NA]
A clinical trial evaluating an electronic cognitive behavioral therapy application for treating Major Depressive Disorder has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder [Phase 2]
The Phase 2 trial evaluating the effects of Seroquel XR on sleep architecture in Major Depressive Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-21Clinical Trial Update: Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients [NA]
The clinical trial evaluating mood and anti-craving effects of varenicline in psychiatric inpatients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Can Additional Drug Therapy Accelerate Response Time to Antidepressants [Phase 4]
A Phase 4 clinical trial investigating whether adding another drug therapy can accelerate response to antidepressants has been withdrawn.